BMJ Best Practice

参考文献

关键文献

Centers for Disease Control and Prevention. Rubella (German measles): 2010 case definition. May 2014. http://www.cdc.gov (last accessed 27 February 2017).

Anon. Rubella. In: Atkinson W, Wolfe S, Hamborsky J, et al, eds. Epidemiology and prevention of vaccine-preventable diseases. The pink book: course textbook, 11 ed. Washington, DC: Public Health Foundation; 2009:257-272.

参考文章

1.  Centers for Disease Control and Prevention. Rubella (German measles): 2010 case definition. May 2014. http://www.cdc.gov (last accessed 27 February 2017).

2.  Morse EE, Zinkham WH, Jackson DP. Thrombocytopenic purpura following rubella infection in children and adults. Arch Int Med. 1966;117:573-579.

3.  Centers for Disease Control and Prevention. Achievements in public health: elimination of rubella and congenital rubella syndrome - United States, 1969-2004. Morb Mortal Wkly Rep. 2005;54:279-282.

4.  Centers for Disease Control and Prevention. Rubella (German measles, three-day measles). Sept 2017 [internet publication].

5.  Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148-155.

6.  Anon. Rubella. In: Atkinson W, Wolfe S, Hamborsky J, et al, eds. Epidemiology and prevention of vaccine-preventable diseases. The pink book: course textbook, 11 ed. Washington, DC: Public Health Foundation; 2009:257-272.

7.  Pan American Health Organization; World Health Organization. Elimination of rubella and congenital rubella syndrome in the Americas. Fact Sheet 2015. April 2015. http://www.paho.org/ (last accessed 27 February 2017).

8.  Centers for Disease Control and Prevention (CDC). Nationwide rubella epidemic--Japan, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:457-462.

9.  McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2013;62:1-34.

10.  World Health Organization. Rubella fact sheet. January 2018 [internet publication].

11.  Lambert N, Strebel P, Orenstein W, et al. Rubella. Lancet. 2015;385:2297-2307.

12.  Public Health England. Complete routine immunisation schedule. July 2017 [internet publication].

13.  Kim DK, Hunter P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):115-118.

14.  Robinson CL, Bernstein H, Romero JR, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-114.

15.  Kim DK, Riley LE, Hunter P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 9;67(5):158-160.

16.  Tingle AJ, Allen M, Petty RE, et al. Rubella-associated arthritis. I: comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann Rheum Dis. 1986;45:110-114.

17.  Gross PA, Portnoy B, Mathies AW Jr, et al. A rubella outbreak among adolescent boys. Am J Dis Child. 1970;119:326-331.

18.  Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(suppl 1):S4-S16.

19.  Ratnam S, Tipples G, Head C, et al. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol. 2000 Jan;38(1):99-104.

20.  Jackson MA, Sommerauer JF. Human herpesviruses 6 and 7. Pediatr Infect Dis J. 2002;21:565-566.

21.  American Academy of Pediatrics Committee on Infectious Diseases. Human herpesvirus 6 (including roseola) and 7. In: Pickering LK, Baker, CJ, Long SJ, et al, eds. 2006 Report of the Committee on Infectious Diseases: red book. Elk Grove Village, IL: American Academy of Pediatrics; 2006.

22.  Chiu SS, Cheung CY, Tse CY, et al. Early diagnosis of primary human herpesvirus 6 infection in childhood: serology, polymerase chain reaction, and virus load. J Infect Dis. 1998;178:1250-1256.

23.  Tanz RR, Gerber MA, Kabat W, et al. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics. 2009;123:437-444.

24.  Doyle S, Kerr S, O'Keeffe G, et al. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods. 2000;90:143-152.

25.  Corcoran A, Doyle SJ. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. Med Microbiol. 2004;53:459-475.

26.  Vuorinen T, Vainionpaa R, Hyypia T. Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin Infect Dis. 2003;37:452-455.

27.  Tilley PA, Walle R, Chow A, et al. Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J Clin Microbiol. 2005;43:4691-4695.

28.  Centers for Disease Control and Prevention. Dengue. January 2016. http://www.cdc.gov/ (last accessed 27 February 2017).

29.  Centers for Disease Control and Prevention. Chikungunya Virus. November 2015. http://www.cdc.gov/ (last accessed 27 February 2017).

30.  Centers for Disease Control and Prevention. Zika virus. February 2017. http://www.cdc.gov/ (last accessed 27 February 2017).

31.  Centers for Disease Control and Prevention. Zika virus: diagnostic testing. November 2016. http://www.cdc.gov/ (last accessed 27 February 2017).

32.  Muller I, Brade V, Hagedorn HJ, et al. Is serological testing a reliable tool in laboratory diagnosis of syphilis? meta-analysis of eight external quality control surveys performed by the German Infection Serology Proficiency Testing Program. J Clin Microbiol. 2006;44:1335-1341.

33.  Bruu AL, Hjetland R, Holter E, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol. 2000;7:451-456.

34.  American Academy of Pediatrics, Kimberlin DW, Brady MT, Jackson MA, Long SS. Red Book, 30th Edition (2015). 2015 Report of the Committee on Infectious Diseases, 30th Edition. 2015. Elk Grove Village, IL: American Academy of Pediatrics; 2015.

35.  Young MK, Cripps AW, Nimmo GR, et al. Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome. Cochrane Database Syst Rev. 2015;(9):CD010586.

36.  Young MK, Cripps AW, Nimmo GR, et al. Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome. Cochrane Database Syst Rev. 2015;(9):CD010586.

37.  Sherman FE, Michaels RH, Kenny FM. Acute encephalopathy (encephalitis) complicating rubella: report of cases with virological studies, cortisol-production determinations, and observations at autopsy. JAMA. 1965;192:675-681.

38.  Bechar M, Davidovich S, Goldhammer G, et al. Neurological complications following rubella infection. J Neurol. 1982;226:283-287.

使用此内容应接受我们的免责声明。